Eurofins Scientific/ERF

-0.37%
-
1D1W1MYTD1YMAX

About Eurofins Scientific

Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.

Ticker

ERF

Sector

Healthcare

Trading on

PAR

Industry

Biotechnology & Drugs

CEO

Gilles Martin

Employees

61,798

Headquarters

Luxembourg, Luxembourg

ERF Metrics

BasicAdvanced
€11.41B
Market cap
45.63
P/E ratio
€1.30
EPS
0.37
Beta
€0.50
Dividend rate
1.69%
Dividend yield
€11.41B
0.36947
€65.24
€44.83
335.38K
€0.50
1.445
1.38
65.497
77.335
37.31%
36.29
8.43%
5.41%
10.48%
6.7%
45.627
1.752
2.237
41.351
0.9%
0.85%
1.69%
-2.94%
-21.02%
6.2%
-8.71%
-9.74%

What the Analysts think about ERF

Analyst Ratings

Majority rating from 16 analysts.
Hold

Price Targets

Average projection from 16 analysts.
1.04% upside
High €84.00
Low €48.00
€58.92
Current price
€59.53
Average price target

ERF Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
4.8% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
€3.31B
2.98%
Net income
€158.7M
4.75%
Profit margin
4.8%
1.69%

ERF Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 18.78%
QuarterlyAnnual
Q4 22
Q2 23
Q4 23
Q2 24
Actual
€1.46
€1.31
€1.56
-
Expected
€1.49
€1.22
€1.31
€1.34
Surprise
-2.01%
7.82%
18.78%
-
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Euronext. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Eurofins Scientific stock?

Eurofins Scientific (ERF) has a market cap of €11.41B as of April 17, 2024.

What is the P/E ratio for Eurofins Scientific stock?

The price to earnings (P/E) ratio for Eurofins Scientific (ERF) stock is 45.63 as of April 17, 2024.

Does Eurofins Scientific stock pay dividends?

Yes, the Eurofins Scientific (ERF) stock pays dividends to shareholders. As of April 17, 2024, the dividend rate is €0.5 and the yield is 1.69%. Eurofins Scientific has a payout ratio of 37.31% on a trailing twelve-month basis.

When is the next Eurofins Scientific dividend payment date?

The next Eurofins Scientific (ERF) dividend payment date is unconfirmed.

What is the beta indicator for Eurofins Scientific?

Eurofins Scientific (ERF) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Eurofins Scientific stock price target?

The target price for Eurofins Scientific (ERF) stock is €59.53, which is 1.04% above the current price of €58.92. This is an average based on projections from 16 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Eurofins Scientific stock

Buy or sell Eurofins Scientific stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing